Sandell Jacquelyn Fahey's most recent trade in Voyager Therapeutics Inc was a trade of 83,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Voyager Therapeutics Inc | Sandell Jacquelyn Fahey | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 83,000 | 83,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Sandell Jacquelyn Fahey | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 41,500 | 123,143 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Sandell Jacquelyn Fahey | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 4.45 per share. | 11 Feb 2025 | 4,358 | 81,643 (0%) | 0% | 4.4 | 19,393 | Common Stock |
| Voyager Therapeutics Inc | Sandell Jacquelyn Fahey | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 5.82 per share. | 02 Oct 2024 | 5,999 | 86,001 (0%) | 0% | 5.8 | 34,914 | Common Stock |
| Voyager Therapeutics Inc | Fahey Sandell Jacquelyn | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 62,000 | 62,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Sandell Fahey Jacquelyn | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 31,000 | 92,000 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Sandell Jacquelyn Fahey | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2023 | 122,000 | 122,000 | - | - | Stock Option (Right to Buy) |